Wells Fargo & Company MN raised its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 1.5% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 571,918 shares of the company's stock after purchasing an additional 8,611 shares during the quarter. Wells Fargo & Company MN owned 0.24% of Cardinal Health worth $67,641,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. Stifel Financial Corp grew its position in shares of Cardinal Health by 5.2% during the 3rd quarter. Stifel Financial Corp now owns 156,655 shares of the company's stock valued at $17,313,000 after acquiring an additional 7,716 shares during the period. National Bank of Canada FI increased its position in Cardinal Health by 59.6% in the third quarter. National Bank of Canada FI now owns 157,183 shares of the company's stock worth $17,372,000 after buying an additional 58,716 shares in the last quarter. Y Intercept Hong Kong Ltd raised its stake in shares of Cardinal Health by 15.3% in the third quarter. Y Intercept Hong Kong Ltd now owns 15,203 shares of the company's stock worth $1,680,000 after buying an additional 2,015 shares during the period. Nomura Asset Management Co. Ltd. lifted its position in shares of Cardinal Health by 7.9% during the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 490,463 shares of the company's stock valued at $54,206,000 after buying an additional 35,921 shares in the last quarter. Finally, Barclays PLC grew its stake in shares of Cardinal Health by 8.2% during the 3rd quarter. Barclays PLC now owns 707,404 shares of the company's stock valued at $78,183,000 after acquiring an additional 53,851 shares during the period. Institutional investors own 87.17% of the company's stock.
Cardinal Health Trading Up 1.4 %
Shares of CAH stock traded up $1.88 during trading hours on Monday, hitting $133.65. The company's stock had a trading volume of 196,070 shares, compared to its average volume of 2,174,438. The company has a 50 day moving average of $129.33 and a 200 day moving average of $122.48. Cardinal Health, Inc. has a 12-month low of $93.17 and a 12-month high of $139.50. The stock has a market cap of $32.29 billion, a PE ratio of 24.93, a price-to-earnings-growth ratio of 1.49 and a beta of 0.61.
Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.
Cardinal Health Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be issued a $0.5056 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a yield of 1.51%. Cardinal Health's payout ratio is 37.69%.
Analyst Ratings Changes
CAH has been the topic of several analyst reports. Evercore ISI raised shares of Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 price target on the stock in a report on Tuesday, January 7th. Morgan Stanley boosted their target price on Cardinal Health from $136.00 to $142.00 and gave the company an "overweight" rating in a research report on Friday, January 31st. Bank of America increased their target price on shares of Cardinal Health from $150.00 to $155.00 and gave the company a "buy" rating in a research note on Friday. JPMorgan Chase & Co. raised their price objective on shares of Cardinal Health from $142.00 to $145.00 and gave the stock a "neutral" rating in a research note on Tuesday, February 4th. Finally, TD Cowen raised Cardinal Health from a "hold" rating to a "buy" rating and lifted their target price for the company from $130.00 to $144.00 in a research report on Wednesday, January 8th. Four equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $140.86.
Read Our Latest Analysis on CAH
Cardinal Health Company Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Articles
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
